ACCELERON PHARMA INC Insider Trading for April 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for April 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Option Exercise | M | 1.80 | 5,000 | 9,000 | 2,300 | |
| Apr 30 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Buy | M | 1.80 | 5,000 | 9,000 | 38,200 | 33.2 K to 38.2 K (+15.06 %) |
| Apr 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 0.48 | 4,000 | 1,920 | 16,000 | |
| Apr 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 33.50 | 1,000 | 33,500 | 15,500 | 16.5 K to 15.5 K (-6.06 %) |
| Apr 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 33.53 | 4,000 | 134,120 | 32,004 | 36 K to 32 K (-11.11 %) |
| Apr 21 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 0.48 | 4,000 | 1,920 | 36,004 | 32 K to 36 K (+12.50 %) |
| Apr 17 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 3.88 | 12,000 | 46,560 | 23,500 | |
| Apr 17 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 3.88 | 12,000 | 46,560 | 32,004 | 20 K to 32 K (+59.99 %) |
| Apr 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 33,500 | |
| Apr 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 33.58 | 2,000 | 67,160 | 52,656 | 54.7 K to 52.7 K (-3.66 %) |
| Apr 17 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 2,000 | 7,760 | 54,656 | 52.7 K to 54.7 K (+3.80 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 83,751 | |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 88,751 | |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 35.50 | 500 | 17,750 | 25,000 | 25.5 K to 25 K (-1.96 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 34.80 | 4,500 | 156,600 | 25,500 | 30 K to 25.5 K (-15.00 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 30,000 | 25 K to 30 K (+20.00 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 35.52 | 250 | 8,880 | 25,000 | 25.3 K to 25 K (-0.99 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 34.82 | 1,750 | 60,935 | 25,250 | 27 K to 25.3 K (-6.48 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 2,000 | 7,760 | 27,000 | 25 K to 27 K (+8.00 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 3.88 | 5,000 | 19,400 | 82,500 | |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 35.45 | 500 | 17,725 | 12,584 | 13.1 K to 12.6 K (-3.82 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.80 | 4,500 | 156,600 | 13,084 | 17.6 K to 13.1 K (-25.59 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 3.88 | 5,000 | 19,400 | 17,584 | 12.6 K to 17.6 K (+39.73 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 35.39 | 2,100 | 74,319 | 12,584 | 14.7 K to 12.6 K (-14.30 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.75 | 7,900 | 274,525 | 14,684 | 22.6 K to 14.7 K (-34.98 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 35.43 | 500 | 17,715 | 22,584 | 23.1 K to 22.6 K (-2.17 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.80 | 4,500 | 156,600 | 23,084 | 27.6 K to 23.1 K (-16.31 %) |
| Apr 08 2015 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Option Exercise | A | 34.14 | 10,000 | 341,400 | 10,000 |